These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 12544532

  • 21. Long-term infliximab treatment for Behçet's disease.
    Takamoto M, Kaburaki T, Numaga J, Fujino Y, Kawashima H.
    Jpn J Ophthalmol; 2007; 51(3):239-40. PubMed ID: 17554493
    [No Abstract] [Full Text] [Related]

  • 22. Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet's disease.
    Iwata S, Saito K, Yamaoka K, Tsujimura S, Nawata M, Hanami K, Tanaka Y.
    Mod Rheumatol; 2011 Apr; 21(2):184-91. PubMed ID: 21052764
    [Abstract] [Full Text] [Related]

  • 23. Intra-articular anti-tumor necrosis factor alpha antibody in recalcitrant arthritis of Behçet's disease.
    Andonopoulos AP, Meimaris N, Daoussis D, Bounas A, Yiannopoulos G.
    Clin Exp Rheumatol; 2003 Apr; 21(4 Suppl 30):S57-8. PubMed ID: 14727465
    [No Abstract] [Full Text] [Related]

  • 24. Induction of regulatory T cells by infliximab in Behcet's disease.
    Sugita S, Yamada Y, Kaneko S, Horie S, Mochizuki M.
    Invest Ophthalmol Vis Sci; 2011 Jan 21; 52(1):476-84. PubMed ID: 20861484
    [Abstract] [Full Text] [Related]

  • 25. Effect of infliximab on refractory uveitis in Behcet's disease.
    Sayarlioglu M, Cinal A, Topcu N, Demirok A.
    Ann Pharmacother; 2004 May 21; 38(5):901-2. PubMed ID: 15010522
    [No Abstract] [Full Text] [Related]

  • 26. The effect of anti-tumour necrosis factor alpha (infliximab) on sight-threatening uveitis in a patient with Behçet's disease.
    Morris DS, Gavin MP, Sturrock RD.
    Adv Exp Med Biol; 2003 May 21; 528():557-9. PubMed ID: 12918763
    [No Abstract] [Full Text] [Related]

  • 27. Intestinal Behçet's disease: maintenance of remission with adalimumab monotherapy.
    Ariyachaipanich A, Berkelhammer C, Nicola H.
    Inflamm Bowel Dis; 2009 Dec 21; 15(12):1769-71. PubMed ID: 19177427
    [No Abstract] [Full Text] [Related]

  • 28. Infliximab in refractory uveitis due to Behçet's disease.
    Wechsler B, Sablé-Fourtassou R, Bodaghi B, Huong DL, Cassoux N, Badelon I, Fain O, LeHoang P, Piette JC.
    Clin Exp Rheumatol; 2004 Dec 21; 22(4 Suppl 34):S14-6. PubMed ID: 15515776
    [Abstract] [Full Text] [Related]

  • 29. Improvement of neurological and ocular symptoms of Behçet's disease after the introduction of infliximab.
    Barešić M, Reihl M, Habek M, Vukojević N, Anić B.
    Rheumatol Int; 2018 Jul 21; 38(7):1301-1306. PubMed ID: 29777341
    [Abstract] [Full Text] [Related]

  • 30. Successful use of infliximab in a patient with neuro-Behçet's disease.
    Abalos-Medina GM, Sánchez-Cano D, Ruiz-Villaverde G, Ruiz-Villaverde R, Quirosa Flores S, Raya Alvarez E.
    Int J Rheum Dis; 2009 Sep 21; 12(3):264-6. PubMed ID: 20374357
    [Abstract] [Full Text] [Related]

  • 31. Mimicry between intestinal Behçet's disease and inflammatory bowel disease.
    Rodrigues-Pinto E, Magro F, Pimenta S, Guimarães J, Macedo G.
    J Crohns Colitis; 2014 Jul 21; 8(7):714-5. PubMed ID: 24389388
    [No Abstract] [Full Text] [Related]

  • 32. Efficacy of infliximab for induction and maintenance of remission in intestinal Behçet's disease.
    Naganuma M, Sakuraba A, Hisamatsu T, Ochiai H, Hasegawa H, Ogata H, Iwao Y, Hibi T.
    Inflamm Bowel Dis; 2008 Sep 21; 14(9):1259-64. PubMed ID: 18393375
    [Abstract] [Full Text] [Related]

  • 33. Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab.
    Leccese P, D'Angelo S, Angela P, Coniglio G, Olivieri I.
    Clin Exp Rheumatol; 2010 Sep 21; 28(4 Suppl 60):S102. PubMed ID: 20868587
    [No Abstract] [Full Text] [Related]

  • 34. Behçet's syndrome in a family with inflammatory bowel disease.
    Yim CW, White RH.
    Arch Intern Med; 1985 Jun 21; 145(6):1047-50. PubMed ID: 4004429
    [Abstract] [Full Text] [Related]

  • 35. Successful treatment of long-standing neuro-Behçet's disease with infliximab.
    Sarwar H, McGrath H, Espinoza LR.
    J Rheumatol; 2005 Jan 21; 32(1):181-3. PubMed ID: 15630746
    [Abstract] [Full Text] [Related]

  • 36. Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet's syndrome.
    Licata G, Pinto A, Tuttolomondo A, Banco A, Ciccia F, Ferrante A, Triolo G.
    Ann Rheum Dis; 2003 Mar 21; 62(3):280-1. PubMed ID: 12594127
    [No Abstract] [Full Text] [Related]

  • 37. Resolution of Behçet's syndrome associated pulmonary arterial aneurysms with infliximab.
    Schreiber BE, Noor N, Juli CF, Haskard DO.
    Semin Arthritis Rheum; 2011 Dec 21; 41(3):482-7. PubMed ID: 21546064
    [Abstract] [Full Text] [Related]

  • 38. Successful treatment of recalcitrant genital ulcers of Behçet's disease with adalimumab after failure of infliximab and etanercept.
    Olivieri I, D' Angelo S, Padula A, Leccese P, Mennillo GA.
    Clin Exp Rheumatol; 2009 Dec 21; 27(2 Suppl 53):S112. PubMed ID: 19796550
    [No Abstract] [Full Text] [Related]

  • 39. Worsening of osteomalacia in a patient successfully treated for neuro-Behçet's disease with infliximab.
    Madanat WY, Madanat AY.
    Clin Exp Rheumatol; 2008 Dec 21; 26(4 Suppl 50):S128-9. PubMed ID: 19026133
    [No Abstract] [Full Text] [Related]

  • 40. [Infliximab treatment for Behçet's disease--beginning of the biological drug era].
    Namba K.
    Nippon Ganka Gakkai Zasshi; 2010 Feb 21; 114(2):85-6. PubMed ID: 20187504
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.